Mohini Health & Hygiene Ltd
Incorporated in 2009, Mohini Health and Hygiene Ltd is engaged in the business of healthcare and hygiene products.[1]
- Market Cap ₹ 48.5 Cr.
- Current Price ₹ 26.6
- High / Low ₹ 45.9 / 25.6
- Stock P/E 88.2
- Book Value ₹ 51.5
- Dividend Yield 0.00 %
- ROCE -3.85 %
- ROE -8.88 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.52 times its book value
- Debtor days have improved from 45.6 to 25.5 days.
- Company's working capital requirements have reduced from 93.4 days to 73.9 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.96% over past five years.
- Company has a low return on equity of 4.81% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91 | 122 | 137 | 169 | 147 | 129 | 137 | 136 | 192 | 200 | 168 | 144 | 181 | |
| Sales growth | +87% | +34% | +12% | -13% | -12% | +6% | -1% | +41% | +4% | -16% | -14% | +21% | |
| 86 | 112 | 127 | 152 | 127 | 119 | 120 | 126 | 179 | 186 | 156 | 147 | 179 | |
| Operating Profit | 5 | 10 | 10 | 17 | 20 | 11 | 18 | 11 | 13 | 14 | 12 | -3 | 2 |
| OPM % | 5% | 8% | 7% | 10% | 14% | 8% | 13% | 8% | 7% | 7% | 7% | -1.8% | 1.1% |
| 0 | 1 | 3 | 1 | 1 | 6 | 0 | 7 | 6 | 8 | 4 | -6 | 3 | |
| Interest | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 7 |
| Depreciation | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 | 4 |
| Profit before tax | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 9 | 11 | 13 | 8 | -17 | -7 |
| Tax % | 24% | 10% | 27% | 30% | 27% | 16% | 25% | 30% | 36% | 20% | 31% | -1% | |
| 2 | 4 | 6 | 5 | 7 | 7 | 6 | 6 | 7 | 11 | 6 | -17 | -7 | |
| EPS in Rs | 1.45 | 2.86 | 4.19 | 2.74 | 4.02 | 3.58 | 3.25 | 3.15 | 3.72 | 5.86 | 3.21 | -9.14 | -4.12 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 16% | 0% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | -9% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -27% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | -9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 | 70 | 76 |
| 52 | 58 | 65 | 50 | 44 | 35 | 43 | 44 | 28 | 23 | 34 | 35 | 152 | |
| 18 | 11 | 18 | 29 | 23 | 27 | 26 | 30 | 21 | 17 | 29 | 30 | 27 | |
| Total Liabilities | 84 | 87 | 107 | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 154 | 274 |
| 44 | 42 | 41 | 65 | 64 | 61 | 65 | 53 | 49 | 45 | 42 | 40 | 38 | |
| CWIP | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 6 | 18 | 19 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 2 |
| 40 | 44 | 44 | 73 | 69 | 71 | 81 | 104 | 89 | 93 | 118 | 93 | 215 | |
| Total Assets | 84 | 87 | 107 | 138 | 133 | 134 | 147 | 157 | 138 | 140 | 168 | 154 | 274 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 3 | 13 | 3 | 14 | 16 | 10 | -5 | 26 | 14 | 29 | 9 | |
| 0 | -2 | -19 | -6 | -4 | -2 | -8 | 8 | -6 | -1 | -29 | -14 | |
| 0 | -1 | 6 | 5 | -12 | -14 | -3 | -3 | -20 | -10 | 10 | -3 | |
| Net Cash Flow | 0 | 0 | -0 | 2 | -2 | 1 | -0 | 0 | 0 | 4 | 9 | -9 |
| Free Cash Flow | 0 | 1 | -6 | -3 | 10 | 14 | 2 | 3 | 23 | 12 | 3 | -8 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 0% | 27% | 128% | 23% | 79% | 151% | 58% | -30% | 217% | 121% | 259% | -337% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 133 | 49 | 64 | 79 | 65 | 60 | 62 | 109 | 67 | 72 | 39 | 25 |
| Inventory Days | 15 | 58 | 37 | 38 | 65 | 94 | 127 | 110 | 65 | 55 | 117 | 134 |
| Days Payable | 44 | 14 | 13 | 30 | 14 | 30 | 36 | 43 | 16 | 10 | 29 | 19 |
| Cash Conversion Cycle | 105 | 93 | 88 | 87 | 116 | 124 | 153 | 175 | 116 | 117 | 127 | 141 |
| Working Capital Days | 43 | 24 | 1 | 39 | 54 | 65 | 63 | 95 | 96 | 106 | 101 | 74 |
| ROCE % | 6% | 12% | 13% | 14% | 11% | 11% | 10% | 12% | 14% | 14% | -4% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Installed Bleaching Capacity MT per annum ・Standalone data |
|
|||||||||||
| Number of Permanent Employees employees ・Standalone data |
||||||||||||
| Capacity Utilization % ・Standalone data |
||||||||||||
| Export Revenue Share % ・Standalone data |
||||||||||||
| Production Volume - Bleached Cotton MT ・Standalone data |
||||||||||||
| Sales Realisation per Tonne INR per tonne ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Outcome of Board Meeting
- Board approved FY26 results, deferred rights issue, and subsidiary's ₹12 crore acquisition of Alpine Developers.
-
Outcome of Board Meeting
- Board approved subsidiary’s Rs12 crore acquisition of Alpine Developers; deferred rights issue; H1 FY27 results.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Regulation 74(5) certificate for demat/remat details for quarter ended September 30, 2026.
-
Appointment
- Shareholders approved auditor appointments and independent director appointment at 17th AGM on September 30, 2026.
-
Appointment
- AGM approved auditor reappointment and appointed Renu Lata Rajani as independent director.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
-
Annual Report 2022
from nse
-
Annual Report 2021
from nse
-
Annual Report 2020
from nse
-
Annual Report 2019
from nse
-
Annual Report 2018
from nse
Business Overview:[1][2]
MHHL is promoted by the Bansal family. It is engaged in cotton processing and manufacturing of surgical, bleached, absorbent cotton, and value-added products. It also recycles cotton waste, which finds applications
in medical, hygiene, and cosmetic-related purposes.